WeightWatchers to offer compounded GLP-1 weight-loss drugs
WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy.
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide
WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its WeightWatchers Clinic members, expanding the accessibility of popular weight loss medications to its members at a more affordable price.
WeightWatchers is getting in on the off-brand weight loss drug game — and selling them cheap
WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in the industry.
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.
WeightWatchers CEO who oversaw move into weight loss drugs abruptly leaves role
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a WeightWatchers board member and former Shake Shack executive, was made interim chief executive.
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight management interventions that are underpinned by the comprehensive,
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering
Shares of WW International Inc., known as WeightWatchers, soared 18% Tuesday, after the weight-management company announced the addition of compounded GLP-1 obesity treatments to its offering. The new offering starts at $129.
Not Many Employers Cover GLP-1 Weight Loss Drugs
Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.
The Holy Mess on MSN11d
New Updates! Weight Watchers Changes for 2024
What’s going on with Weight Watchers? With the CEO stepping down, a new body-positive approach, continual app changes, ...
4029tv2d
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC ...
Taste of Home on MSN13d
Here’s How to Succeed on the New Weight Watchers Program
Reach those weight loss goals once and for all! The post Here’s How to Succeed on the New Weight Watchers Program appeared ...
Ticker: WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
Weight Watchers Stock Rises 38% On Plan To Sell Obesity Drugs
Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...
The Root12d
A Look at Oprah's Complicated, Inspiring Weight Loss Journey Over the Years
The media mogul has oft been the go-to girl for weight loss inspiration, tips, and tricks for years. So let's take a look at ...
Cook Eat Go on MSN5d
3 Ingredient Strawberry Weight Watcher Muffins!
Weight Watchers Strawberry Muffins are the perfect light treat to make at home! I am a huge fan of baking, and the easie ...
WeightWatchers: Weight loss program cancels all in-person workshops in Australia and New Zealand
The weight loss program spruiked by some of the world’s top celebrities has outraged customers by the shock move.